Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.550
-0.080 (-2.20%)
Dec 3, 2024, 1:59 PM EST - Market open
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $549.89 million as of December 3, 2024. Its market cap has increased by 90.67% in one year.
Market Cap
549.89M
Enterprise Value
488.44M
1-Year Change
90.67%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has increased from $124.83M to $549.89M, an increase of 340.50%. That is a compound annual growth rate of 30.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 562.28M | 73.87% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | 241.63M | 276.02% |
| Dec 31, 2019 | 64.26M | -48.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 574.54M |
| SI-BONE | 568.68M |
| Surmodics | 565.16M |
| Ironwood Pharmaceuticals | 563.30M |
| Fulgent Genetics | 559.74M |
| Esperion Therapeutics | 551.70M |
| Emergent BioSolutions | 548.34M |
| Health Catalyst | 537.28M |